1 recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Recruiting 1 |
Follow Neoplasm Malignant: new trials by email Literature Review of Neoplasm Malignant trials Research Report on Neoplasm Malignant
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Clinical Study of Calderasib (MK-1084) in People With Advanced Solid Tumors (MK-1084-014) Calderasib, Cetuximab - Neoplasm Malignant | Phase 2 | Recruiting | Merck Sharp & Dohme LLC | 150 | 2025-12-04 | 2026-10-07 |
Neoplasms (1)
Cetuximab (1)
Australia (1) · Canada (1) · Chile (1) · China (1) · Denmark (1) · France (1) · Germany (1) · Greece (1) · Israel (1) · Italy (1) · Japan (1) · Norway (1) · Poland (1) · South Korea (1) · Spain (1)
2025 (1)